Maitalon

Drospirenone/Ethinylestradiol, the active ingredient in Maitalon, is a combined oral contraceptive presented as an oral tablet for oral use. It prevents pregnancy in women of reproductive age.

GNH USA supplies Maitalon as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Maitalon, a combined oral contraceptive, is used within the hormonal contraception pathway to prevent pregnancy.

Contraception (prevention of pregnancy): Provides reliable inhibition of ovulation and prevents fertilization. Family planning: Enables women to plan pregnancies according to personal goals. Menstrual regulation: Helps maintain regular menstrual cycles in many users. Acne improvement: May reduce androgen‑related acne as a secondary benefit in some patients.

Maitalon may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: temporary swelling or discomfort. - Weight gain: modest increase in body weight. - Mood changes: irritability or emotional fluctuations. - Spotting or breakthrough bleeding: irregular bleeding between periods.

Serious or Rare Side Effects: - Venous thromboembolism: deep‑vein thrombosis or pulmonary embolism. - Arterial thrombosis: stroke or myocardial infarction. - Hypertension: new‑onset or worsening high blood pressure. - Liver disorders: cholestasis or hepatic dysfunction. - Severe allergic reaction: anaphylaxis, angioedema, or rash. - Visual disturbances: sudden loss of vision or eye pain.

Before prescribing Maitalon, clinicians should evaluate individual risk factors and counsel patients on safe use. - Assess cardiovascular risk: review history of thrombosis, smoking, hypertension, or obesity. - Avoid use in smokers over 35 years: smoking markedly increases thrombotic risk. - Consider liver function: monitor patients with hepatic disease or elevated liver enzymes. - Monitor blood pressure: watch for new or worsening hypertension during therapy. - Review concomitant medications: check for drugs that may alter hormonal efficacy. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Maitalon can interact with several medicines that affect hormone metabolism or clotting pathways.

Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): reduce contraceptive effectiveness. - Rifampin or griseofulvin: may lower plasma hormone levels. - Certain antiretrovirals (protease inhibitors): alter hormone metabolism.

Moderate Interactions (Monitor Closely): - St. John’s wort: may decrease contraceptive efficacy. - Ketoconazole and other strong antifungals: can increase hormone concentrations. - Diuretics (especially potassium‑sparing): may affect drospirenone’s anti‑mineralocorticoid activity.